Invention Grant
US08535674B2 Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
有权
用抗IL-20抗体治疗乳腺癌并抑制癌症相关的骨丢失
- Patent Title: Treating breast cancer and inhibiting cancer-associated bone loss with anti-IL-20 antibody
- Patent Title (中): 用抗IL-20抗体治疗乳腺癌并抑制癌症相关的骨丢失
-
Application No.: US12815855Application Date: 2010-06-15
-
Publication No.: US08535674B2Publication Date: 2013-09-17
- Inventor: Ming-Shi Chang
- Applicant: Ming-Shi Chang
- Applicant Address: TW Tainan
- Assignee: National Cheng Kung University
- Current Assignee: National Cheng Kung University
- Current Assignee Address: TW Tainan
- Agency: Wolf, Greenfield & Sacks, P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
Use of an anti-IL-20 antibody, either alone or in combination with an anti-RANKL antibody, for treating breast cancer and inhibiting cancer-associated bone loss.
Public/Granted literature
- US20110305698A1 Treating Breast Cancer and Inhibiting Cancer-Associated Bone loss with Anti-IL-20 Antibody Public/Granted day:2011-12-15
Information query
